| #1 | — 0 | GeorgiamuneRegulating signaling pathways to restore immune homeostasis to fight cancer and autoimmune diseases. | Breakout | Raised $92.7M on Jul 16SEC Form D |
| #2 | ▲ 1 | Lindus TherapeuticsLindus Therapeutics is a next-generation drug development company advancing a portfolio of in-licensed assets. | Undisclosed | 2 open roles, 1 new this monthAshby |
| #3 | ▲ 1 | CresilonOur plant-based technology stops traumatic and surgical bleeds in seconds without the need for manual pressure. | Breakout | Raised $29.0M on Apr 24SEC Form D |
| #4 | ▲ 1 | PluristyxPluristyx provides cell therapy solutions to support the manufacturing and development of custom stem cell products. | Early | Raised $9.8M on Jul 1SEC Form D |
| #5 | ▲ 1 | Hyku Biosciences Inc.Hyku Biosciences is developing the next generation of small molecule medicines by targeting histidine, tyrosine | Early | Raised $8.6M on Jul 30SEC Form D |
| #6 | ▲ 1 | Evia BioEvia Bio’s cryopreservation technology enables the entire Cell Therapy supply chain with high product yield, efficacy | Early | Raised $5.5M on Sep 14SEC Form D |
| #7 | ▲ 1 | OncoSynergyNext generation immunotherapies | Early | Raised $6.6M on May 11SEC Form D |
| #8 | ▲ 1 | Peptaris, Inc.Peptaris is building an AI-powered platform to design peptides with the properties they need to become viable medicines. | Early | Raised $4.0M on Jun 1SEC Form D |
| #9 | ▲ 1 | BioGene TherapeuticsBioGene Therapeutics is at the forefront of developing novel therapeutic solutions for metabolic disorders. | Seed | Raised $3.0M on Jun 5SEC Form D |
| #10 | ▲ 1 | Argonaute RNADeveloping safe and reliable methods of temporarily silencing target genes in different tissue cells. | Seed | Raised $1.8M on Sep 9SEC Form D |
| #11 | ▲ 1 | Aqur BiosciencesRevolutionizing cardiovascular health with breakthrough science. | Seed | Raised $1.5M on Sep 3SEC Form D |
| #12 | ▲ 1 | ORF BiologicsORF Biologics pioneers next-generation biologics and cutting-edge technologies for research | Seed | Raised $1.7M on Jul 23SEC Form D |
| #13 | ▲ 1 | Remedium BioWe believe that any disease can be cured. | Seed | Raised $1.5M on May 6SEC Form D |
| #14 | ▲ 1 | MBQ PharmaPrecision Targeting GTPases in Cancer, Autoimmunity and Fibrosis Precision Targeting GTPases in Cancer, Autoimmunity | Seed | Raised $991K on May 15SEC Form D |
| #15 | ▲ 1 | QentorosQentoros develops BIO-PLY™ and a growing pipeline of platelet-derived biologics for high-impact equine conditions. | Seed | Raised $505K on Apr 24SEC Form D |
| #16 | ▲ 1 | Jupiter Biomedical Research, Inc.Jupiter Biomedical Research is a preclinical | Seed | Raised $30K on Sep 15SEC Form D |
| #17 | ▲ 1 | AndelBenefit provider building a fairer way to get life-changing drugs | Undisclosed | |
| #18 | ▲ 1 | eGenesisAt eGenesis, we envision a world in which transplant is accessible to all patients who may benefit. | Undisclosed | |
| #19 | ▲ 1 | ArlequinDesigned for humans, powered by superintelligence. | Early | |
| #20 | ▲ 1 | Cellular IntelligenceWe are building a future where biology is no longer destiny, but design. | Undisclosed | |
| #21 | ▲ 1 | CContralineBiotechnology company pioneering reversible male contraception. | Breakout | |
| #22 | ▲ 1 | Formation BioBuilding the pharma company of the future. | Undisclosed | |
| #23 | ▲ 1 | InstyllaInstylla delivers next-generation liquid embolics for interventional radiology | Breakout | |
| #24 | ▲ 1 | Kamau TherapeuticsGene editing to cure sickle cell disease | Undisclosed | |
| #25 | ▲ 1 | Moonwalk Biosciences, Inc.Pioneering precision epigenetic medicines | Undisclosed | |
| #26 | ▲ 1 | One BiosciencesOne Biosciences is a techbio company utilizing AI-driven single-cell technologies to revolutionize precision medicine | Undisclosed | |
| #27 | ▲ 1 | PharmintPharmint is the Largest Global B2B pharmaceutical marketplace for global buyers & suppliers. | Undisclosed | |
| #28 | ▲ 1 | Stylus MedicineStylus Medicine, Inc. is a biotechnology company dedicated to developing transformative in vivo genetic medicines. | Undisclosed | |
| #29 | ▲ 1 | Valar LabsAI diagnostics for cancer treatment decisions | Early | |
| #30 | ▲ 1 | VitaraVitara is a biomedical technology company reinventing the standard of care for extremely premature newborns | Undisclosed | |
| #31 | ▲ 1 | AAccretion BioTo cure disease, you first have to see it. | Undisclosed | |
| #32 | ▲ 1 | AAlphagridThe traceable hub for unified oncology intelligence | Undisclosed | |
| #33 | ▲ 1 | Amptiv BiosciencesAmptiv is building a programmable chemical control layer for mRNA. | Undisclosed | |
| #34 | ▲ 1 | BioOrbitPharma factories in microgravity for cancer drugs you can inject at home | Undisclosed | |
| #35 | ▲ 1 | Brink TherapeuticsPushing Cell and Gene Therapy over the brink with better enzymes | Undisclosed | |
| #36 | ▲ 1 | CipherXCipherX is redefining tattooing with MicroDot Tattoo technology — small | Undisclosed | |
| #37 | ▲ 1 | CComendComend has permanently shut down. | Undisclosed | |
| #38 | ▲ 1 | Cure 51The first worldwide database of Cancer Outliers. | Undisclosed | |
| #39 | ▲ 1 | DeeplifeAt DeepLife, we harness deep learning on multi-omics data to model cells and efficiently engineer their behavior | Undisclosed | |
| #40 | ▲ 1 | EEasyTellingEmpresas buscam soluções sem saber que a ciência já pode ter a resposta. | Undisclosed | |
| #41 | ▲ 1 | Excelsior SciencesExcelsior Sciences is revolutionizing small molecule innovation. | Early | |
| #42 | ▲ 1 | GenehubWe deserve the right medicine, at the right dose, at the right time. | Undisclosed | |
| #43 | ▲ 1 | HHC MedicalHHC Medical is a health tech startup developing a platform technology for targeted | Undisclosed | |
| #44 | ▲ 1 | ImpriMed, Inc.AI-powered drug response prediction for pet cancer | Undisclosed | |
| #45 | ▲ 1 | IInfinimmuneDerived from human biology, engineered for human health. | Early | |
| #46 | ▲ 1 | Invoke BioThe full-stack, AI-native platform for personalized cancer vaccines | Undisclosed | |
| #47 | ▲ 1 | KolateAIAI-native patient-level outcomes prediction & simulation platform for pharma. | Undisclosed | |
| #48 | ▲ 1 | LLiberate BioDelivering genetic medicines that transcend liver-based limitations, liberating patients from disease | Undisclosed | |
| #49 | ▲ 1 | Molecular Quantum SolutionsTransform your R&D with quantum-powered simulations for chemistry, materials science, and machine learning. | Undisclosed | |
| #50 | ▲ 1 | Nest.Bio Labs | Undisclosed | |
| #51 | ▲ 2 | RRadar TherapeuticsRNA-sensing mRNA therapeutics that target specific cell types | Undisclosed | |
| #52 | ▲ 2 | Resolute ScienceDeveloping a novel class of cancer therapeutics for solid tumors. | Seed | |
| #53 | ▲ 2 | Senti BiosciencesOutsmarting Complex Diseases With More Intelligent Medicines | Undisclosed | |
| #54 | ▲ 2 | YYap株式会社(ヤップ)世界と日本の医薬品・健康産業をつなぎ、人々の健康に貢献することをミッションとしています。 | Undisclosed | |
| #55 | ▲ 2 | Zag BioPioneering thymus-targeted medicines | Undisclosed | |